2023 Annual Meeting | C136 - Basic Science: Neuropathology

Date Tuesday 04/25/23

Time 01:00 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Suzanne Powell, MD

Topic(s) Education, Research, and Methodology

Learning Objectives Participants should be able to recognize common gross, histological, and molecular features of central nervous system disorders, and be able to understand cellular and gross neuropathology in relationship to neurologic disease mechanisms, diagnosis, laboratory studies, imaging, and progression of disease. This program complements Basic Science: Neuroanatomy-All the Lesions, Basic Science: Neuropharmacology, Basic Science: Neurophysiology, but covers independent topics.

CME Available 4.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:15 PM EST	Introduction	Introduction to Neuropathology – Approaches to Images Suzanne Powell, MD
01:15 PM - 02:30 PM EST	Speaker	Tumors – from Gliomas (CNS WHO 2022) to Meningiomas, Metastases and Spinal Cord Tumors Suzanne Powell, MD
02:30 PM - 02:50 PM EST	Break	Break
02:50 PM - 03:30 PM EST	Speaker	Vascular Disease J. Clay Goodman, MD, FAAN
03:30 PM - 04:45 PM EST	Speaker	Metabolic Diseases, Demyelination, and Infections J. Clay Goodman, MD, FAAN
04:45 PM - 05:00 PM EST	Speaker	Neurodevelopmental Disorders Suzanne Powell, MD
05:15 PM - 05:30 PM EST	Speaker	Neurodegenerative Diseases – from Alzheimer’s to Traumatic Brain Injury/CTE (Chronic Traumatic Encephalopathy) J. Clay Goodman, MD, FAAN

Faculty Disclosures
Suzanne Powell, MD	Dr. Powell has nothing to disclose.
J. Clay Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology (ABPN). The institution of an immediate family member of Dr. Goodman has received research support from NIH.